REPL Chart
See on advanced chart >
About
Replimune Group, Inc. are incorporated at Delaware in 2015. The company is a clinical-stage biotechnology company committed to applying they leading expertise in the field of oncolytic immunotherapy to transform the lives of cancer patients. The use they...
Read More
- HighlightA company that developing oncolytic immunotherapy for the treatment of solid tumor types
- ExchangeNASDAQ
- Listing Date07/20/2018
- Established DateInvalid Date
- Full-time Employees331
- Address500 Unicorn Park Drive Suite 303 Woburn MA 01801
- Tel1-781-2229600
- Website
- Fiscal Year End Date03/31
- Security TypeCommon Stock
Industry
Biotechnology